Evidence map›Paper›PMID 42879775›Full record

ArticleJMIR medical informatics2026

Large Language Model-Assisted Review of Clinical Trial Informed Consent for Data Reuse: Retrieval-Augmented Generation Approach.

Lameck Mbangula Amugongo, Lena Schaller, Helene Wendt, R Maarten van Dijk, Enrica Zanuttigh, Claudia Neumann, Andreas Freisinger, Jaroslaw Deska

Abstract read
In one paragraph

Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lameck Mbangula AmugongoBiostatistics and Data Sciences Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, Biberach, Baden-Wuerttenberg, 88397, Germany, 49 (7351) 54-17807.ORCID http://orcid.org/0000-0001-6468-2643
Lena SchallerStaburo GmbH, Munich, Bayern, Germany.ORCID http://orcid.org/0009-0002-7890-6673
Helene WendtStaburo GmbH, Munich, Bayern, Germany.ORCID http://orcid.org/0009-0004-1038-3639
R Maarten van DijkStaburo GmbH, Munich, Bayern, Germany.ORCID http://orcid.org/0000-0001-6000-938X
Enrica ZanuttighStaburo GmbH, Munich, Bayern, Germany.ORCID http://orcid.org/0000-0002-2924-1241
Claudia NeumannBiostatistics and Data Sciences Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, Biberach, Baden-Wuerttenberg, 88397, Germany, 49 (7351) 54-17807.ORCID http://orcid.org/0009-0003-3202-228X
Andreas FreisingerBiostatistics and Data Sciences Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, Biberach, Baden-Wuerttenberg, 88397, Germany, 49 (7351) 54-17807.ORCID http://orcid.org/0009-0009-1412-3742
Jaroslaw DeskaBiostatistics and Data Sciences Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, Biberach, Baden-Wuerttenberg, 88397, Germany, 49 (7351) 54-17807.ORCID http://orcid.org/0009-0001-5652-4909

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Regulatory frameworks such as the Belmont Report, the Common Rule, and the Declaration of Helsinki require informed consent to ensure participants understand a study's purpose and can make voluntary decisions about their involvement. Regulations, including the General Data Protection Regulation (Regulation [EU] 2016/679), further emphasize that consent must be freely given and revocable without disadvantage. Although informed consent forms (ICFs) are intended to be clear and accessible, they have become increasingly lengthy and complex. Large language models (LLMs) offer the potential to navigate and interpret this complexity and have shown promise in biomedical information extraction tasks. However, their susceptibility to hallucinations limits their reliability in high-stakes settings. Retrieval-augmented generation (RAG) can mitigate such errors. Objective: This study evaluates the integration of GPT-4.1 with RAG for reviewing data reuse language in ICFs and its ability to interpret complex ICF language. Methods: First, we processed 438 ICFs from different trials, including multiple countries, languages, and versions of ICFs. Using expertly curated prompts, we extracted information about data reuse using GPT-4.1. By comparing the LLM-generated data reuse outputs with human expert ground truth, we evaluated accuracy and the time required to extract information for each ICF. To further validate the workflow, we evaluated an independent set of 488 ICFs spanning additional trials, languages, and regions. During the validation phase, the workflow was evaluated using a baseline assessment (89 ICFs) followed by 3 iterative optimization rounds assessed on 14, 281, and 104 ICFs, respectively. For this cohort, we assessed the correctness of LLM outputs along with the quality of supporting evidence provided by the model. Results: Across the initial set of 438 ICFs, the system achieved 81.6% accuracy. During validation, the baseline accuracy using the preoptimized prompts was 84.0% (89 documents). Accuracy improved sequentially across the 3 iterative optimization rounds, increasing from 82.3% in the first round (14 documents) to 90.7% in the second round (281 documents), and reaching 92.1% in the third and final round on an independent holdout cohort of 104 documents. Ultimately, using our RAG-based approach, the system accurately extracted data reuse information across multiple languages. Conclusions: Our RAG-based workflow demonstrated the ability to effectively support the ICF review process for data reuse and interpret complex consent language, contributing to improved consistency in ICF evaluations for data reuse.

Indexed as

Clinical Trials as TopicInformation Storage and RetrievalInformed ConsentLarge Language ModelsHumansReproducibility of ResultsAIclinical trialsGPT-4health careICFinformed consent formlarge language modelLLMRAGretrieval-augmented generation

Identifiers

PMID42879775
PMCPMC13671682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.